Ataxia | Russian Federation| PDF | PPT| Case Reports | Symptoms | Treatment

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

  • Ataxia

    Ataxia is typically defined as the presence of abnormal, uncoordinated movements. An unsteady, staggering gait is described as an ataxic gait because walking is uncoordinated and appears to be ‘not ordered’. Ataxia can also refer to a group of neurological disorders in which motor behavior appears uncoordinated.

  • Ataxia

    Causes: Inherited/Genetic: Autosomal Dominant; Autosomal Recessive; X-Linked; Associated with a Mitochondrial Disorder. Acquired: Structural/Demyelinating; Toxic/Metabolic; Paraneoplastic; Infectious/Postinfectious; Autoimmune. Idiopathic: Cerebellar form of multiple system atrophy (known as MSA); Idiopathic cerebellar degeneration. 

  • Ataxia

    Therapy for ataxic patients is multi-modal. Pharmacological treatment has been beneficial in a small number of patients with specific ataxias and further research is ongoing worldwide. GABAergic agents such as clonazepam, beta-blockers such as propranolol, or Primidone may reduce the prominence of some cerebellar tremors. The Prevalence of Ataxia is 0.3 per 100 000 (or 1 in 330 000).The region east of Moscow with a prevalence of 1 in 270 000  and in central Asia with an overall prevalence of 1 in 200 000.

High Impact List of Articles

Conference Proceedings